Polymorphic Effects of Cytochrome P450 3A5 on Pharmacokinetics of Maraviroc and Its Metabolites

Clinical trial NCT01980329 · COMPLETED

Trial details

NCT number: NCT01980329
Sponsor: Johns Hopkins University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cytochrome P450 CYP3A5 Enzyme Polymorphism Healthy Subjects Pharmacokinetics of Maraviroc

Start date: 2013-01-01
Primary completion: 2014-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.